₹42.3*
MRP ₹47
10% off
₹39.95*
MRP ₹47
15% CB
₹7.05 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Prescription drugWhats That
Product Substitutes
Composition
ACETYLCYSTEINE-400MG
Manufacturer/Marketer
Unb-United Biotech
Consume Type
PARENTERAL
Return Policy
Not Returnable
Expires on or after
Apr-24
for this medicine
Drug-Drug Interactions
No Drug - Drug interactions found in our data. We may lack specific data on this medicine and are actively working to update our database. Consult your doctor for personalized advice
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
Drug-Diseases Interactions
ACETYLCYSTEINE-400MGHepatic failure, not elsewhere classified
Severe
ACETYLCYSTEINE-400MGAsthma
Moderate
Drug-Diseases Interactions
Login/Sign Up
ACETYLCYSTEINE-400MGHepatic failure, not elsewhere classified
Severe
How does the disease interact with Mucosys 20% Injection 2 ml:
For individuals who have encephalopathy brought on by hepatic failure, the use of Mucosys 20% Injection 2 ml should be stopped in order to prevent further nitrogenous material ingestion.
How to manage the interaction:
Mucosys 20% Injection 2 ml should be discontinued in patients with encephalopathy (permanent or temporary brain damage) due to liver failure.
For individuals who have encephalopathy brought on by hepatic failure, the use of Mucosys 20% Injection 2 ml should be stopped in order to prevent further nitrogenous material ingestion.
How to manage the interaction:
Mucosys 20% Injection 2 ml should be discontinued in patients with encephalopathy (permanent or temporary brain damage) due to liver failure.
ACETYLCYSTEINE-400MGAsthma
Moderate
How does the disease interact with Mucosys 20% Injection 2 ml:
When treating asthmatic patients or situations where bronchospasm has occurred in the past, Mucosys 20% Injection 2 ml should be administered cautiously. When starting and continuing Mucosys 20% Injection 2 ml medication, patients with asthma should be closely monitored.
How to manage the interaction:
Mucosys 20% Injection 2 ml should be used with caution in asthma patients or where there is a history of bronchospasm (tightening of muscles lining airways). Asthma patients should be closely monitored during the initiation of and throughout Mucosys 20% Injection 2 ml therapy.
When treating asthmatic patients or situations where bronchospasm has occurred in the past, Mucosys 20% Injection 2 ml should be administered cautiously. When starting and continuing Mucosys 20% Injection 2 ml medication, patients with asthma should be closely monitored.
How to manage the interaction:
Mucosys 20% Injection 2 ml should be used with caution in asthma patients or where there is a history of bronchospasm (tightening of muscles lining airways). Asthma patients should be closely monitored during the initiation of and throughout Mucosys 20% Injection 2 ml therapy.
ACETYLCYSTEINE-400MGOther disorders of fluid, electrolyte and acid-base balance
Moderate
How does the disease interact with Mucosys 20% Injection 2 ml:
Mucosys 20% Injection 2 ml administered intravenously may lead to fluid overload, which may result in hyponatremia, seizures, and even death.
How to manage the interaction:
To avoid fluid overload, a diluted dose is recommended, especially in patients less than 40 kg and those requiring fluid restrictions.
Mucosys 20% Injection 2 ml administered intravenously may lead to fluid overload, which may result in hyponatremia, seizures, and even death.
How to manage the interaction:
To avoid fluid overload, a diluted dose is recommended, especially in patients less than 40 kg and those requiring fluid restrictions.
ACETYLCYSTEINE-400MGOther diseases of digestive system
Moderate
How does the disease interact with Mucosys 20% Injection 2 ml:
Mucosys 20% Injection 2 ml use may make vomiting worse. The risk of gastrointestinal haemorrhage should be assessed in patients with peptic ulcer disease.
How to manage the interaction:
Patients with peptic ulcer disease should be evaluated for the risk of gastrointestinal bleeding. In case of gastric haemorrhage, Mucosys 20% Injection 2 ml is advised if your doctor considers benefit for you is greater than risk.
Mucosys 20% Injection 2 ml use may make vomiting worse. The risk of gastrointestinal haemorrhage should be assessed in patients with peptic ulcer disease.
How to manage the interaction:
Patients with peptic ulcer disease should be evaluated for the risk of gastrointestinal bleeding. In case of gastric haemorrhage, Mucosys 20% Injection 2 ml is advised if your doctor considers benefit for you is greater than risk.
Author Details
_0.jpg?tr=q-80,f-webp,w-100,dpr-6,c-at_max)
Mucosys 20% Injection 2 ml Substitute
Mucyst 400 mg Injection 2 ml
by Others
₹23.65per tabletNacel 400 mg Injection 2 ml
by Others
₹23.65per tabletImmunac Tablet 10's
by Others
₹11.25per tablet
